Femtrace

Femtrace is a brand name of estradiol, approved by the FDA in the following formulation(s):

FEMTRACE (estradiol acetate - tablet; oral)

• 
  Manufacturer: WARNER CHILCOTT
  
  Approval date: August 20, 2004
  
  Strength(s): 0.45MG, 0.9MG, 1.8MG ^[RLD]

Has a generic version of Femtrace been approved?

No. There is currently no therapeutically equivalent version of Femtrace available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Femtrace. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
  Patent 6,962,908
  Issued: November 8, 2005
  Inventor(s): Aloba; Oluwole T. & deVries; Tina M.
  Assignee(s): Warner Chilcott Company Inc.
  A pharmaceutical dosage unit for oral administration to a human female comprising a therapeutically effective amount of 17β-estradiol-3-lower alkanoate, most preferably 17β-estradiol-3-acetate, and a pharmaceutically acceptable carrier is disclosed. Also disclosed is a method for treating a human female in need of 17β-estradiol and a contraceptive method by oral administration of the pharmaceutical dosage unit and a method of preparing a pharmaceutical composition that may be used to form the pharmaceutical dosage unit of the invention.
  
  Patent expiration dates:
  
  
  • December 21, 2021
    
    ✓ 
    Drug product
  
  



• 
  Oral pharmaceutical products containing 17β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
  Patent 7,572,779
  Issued: August 11, 2009
  Inventor(s): Aloba; Oluwole T. & deVries; Tina M
  Assignee(s): Warner Chilcott Company LLC
  A pharmaceutical dosage unit for oral administration to a human female comprising a therapeutically effective amount of 17β-estradiol-3-lower alkanoate, most preferably 17β-estradiol-3-acetate, and a pharmaceutically acceptable carrier is disclosed. Also disclosed is a method for treating a human female in need of 17β-estradiol and a contraceptive method by oral administration of the pharmaceutical dosage unit and a method of preparing a pharmaceutical composition that may be used to form the pharmaceutical dosage unit of the invention.
  
  Patent expiration dates:
  
  
  • October 2, 2025
    
    ✓ 
    Patent use: TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE
  
  



• 
  Oral pharmaceutical products containing 17β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
  Patent 7,799,771
  Issued: September 21, 2010
  Inventor(s): Aloba; Oluwole T. & deVries; Tina M.
  Assignee(s): Warner Chilcott Company, LLC.
  A pharmaceutical dosage unit for oral administration to a human female comprising a therapeutically effective amount of 17β-estradiol-3-lower alkanoate, most preferably 17β-estradiol-3-acetate, and a pharmaceutically acceptable carrier is disclosed. Also disclosed is a method for treating a human female in need of 17β-estradiol and a contraceptive method by oral administration of the pharmaceutical dosage unit and a method of preparing a pharmaceutical composition that may be used to form the pharmaceutical dosage unit of the invention.
  
  Patent expiration dates:
  
  
  • December 21, 2021
    
    ✓ 
    Drug product
  
  

See also...

• Femtrace Consumer Information (Drugs.com)
• Femtrace Consumer Information (Wolters Kluwer)
• Femtrace Consumer Information (Cerner Multum)
• Estradiol Consumer Information (Drugs.com)
• Estradiol Consumer Information (Wolters Kluwer)
• Estradiol Acetate Consumer Information (Wolters Kluwer)
• Estradiol Cypionate Consumer Information (Wolters Kluwer)
• Estradiol Gel Consumer Information (Wolters Kluwer)
• Estradiol Gel Packets Consumer Information (Wolters Kluwer)
• Estradiol Patch Consumer Information (Wolters Kluwer)
• Estradiol Ring Consumer Information (Wolters Kluwer)
• Estradiol Spray Consumer Information (Wolters Kluwer)
• Estradiol Valerate Consumer Information (Wolters Kluwer)
• Estradiol Weekly Patch Consumer Information (Wolters Kluwer)
• Estring Ring Consumer Information (Wolters Kluwer)
• Estradiol injection Consumer Information (Cerner Multum)
• Estradiol oral Consumer Information (Cerner Multum)
• Estradiol topical for use on skin Consumer Information (Cerner Multum)
• Estradiol transdermal Consumer Information (Cerner Multum)
• Estradiol vaginal Consumer Information (Cerner Multum)
• Estradiol AHFS DI Monographs (ASHP)